Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Brazilian Institute of Regenerative Medicine (BIRM) is a specialized medical and research organization dedicated to the advancement of orthobiologics and regenerative therapies. Based in Brazil, the institute focuses on treating musculoskeletal disorders and sports-related injuries through minimally invasive procedures. Their primary clinical expertise includes the application of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and other cell-based modalities to promote tissue healing and cartilage regeneration. BIRM is recognized for its contributions to clinical research and its role in educating healthcare professionals on the latest techniques in regenerative orthopedics. The institute aims to provide innovative alternatives to traditional surgery for conditions such as chronic tendinopathy and osteoarthritis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brazilian Institute of Regenerative Medicine.